Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ResMed Inc (NYSE:RMD)

58.44
Delayed Data
As of May 27
 +0.22 / +0.38%
Today’s Change
48.99
Today|||52-Week Range
61.23
+8.85%
Year-to-Date
ResMed Posts Mixed Q3 Results, Brightree Buyout on Track
May 26 / Zacks.com - Paid Partner Content
High Quality Guru Stocks: EMC, Bed Bath & Beyond
May 24 / GuruFocus News - Paid Partner Content
ResMed: Positive CAT-HF Study Results to Drive ASV Sales
May 25 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close58.22
Today’s open58.13
Day’s range58.13 - 58.61
Volume552,480
Average volume (3 months)1,089,733
Market cap$8.2B
Dividend yield2.05%
Data as of 4:02pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+3.35%
Earnings growth (this year)+1.69%
Earnings growth (next 5 years)+10.70%
Revenue growth (last year)+7.97%
P/E ratio23.9
Price/Sales4.79
Price/Book5.14

Competitors

 Today’s
change
Today’s
% change
VARVarian Medical Syste...+0.15+0.18%
TFXTeleflex Inc+1.42+0.89%
CMNCantel Medical Corp+0.40+0.60%
LIVNLivaNova PLC+0.47+0.96%
Data as of 4:02pm ET, 05/27/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$0.74
Annual revenue (last year)$1.7B
Annual profit (last year)$352.9M
Net profit margin21.02%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Mick Farrell
President &
Chief Operating Officer
Robert Andrew Douglas
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs